High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders

Conditions: Plasma Cell Disorder Interventions: Drug: 75gm HDAA; Drug: 100gm HDAA; Drug: 125gm HDAA Sponsors: University of Arkansas; University of Iowa Not yet recruiting

Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials